132 related articles for article (PubMed ID: 33205324)
1. Role of supportive care in improving the quality of life and reducing unscheduled hospital care in patients with metastatic breast cancer.
Arnaud A; Grenier J; Boustany R; Kirscher S; Mege A; de Rauglaudre G; Vazquez L; Debourdeau P
Support Care Cancer; 2021 Jul; 29(7):3735-3742. PubMed ID: 33205324
[TBL] [Abstract][Full Text] [Related]
2. Quality of life and care needs in women with estrogen positive metastatic breast cancer: a qualitative study.
Lee Mortensen G; Madsen IB; Krogsgaard R; Ejlertsen B
Acta Oncol; 2018 Jan; 57(1):146-151. PubMed ID: 29202668
[TBL] [Abstract][Full Text] [Related]
3. The Support, Education, and Advocacy (SEA) Program of Care for Women With Metastatic Breast Cancer: A Nurse-Led Palliative Care Demonstration Program.
Reiser V; Rosenzweig M; Welsh A; Ren D; Usher B
Am J Hosp Palliat Care; 2019 Oct; 36(10):864-870. PubMed ID: 30974954
[TBL] [Abstract][Full Text] [Related]
4. Supportive care needs and quality of life in patients with breast and gynecological cancer attending inpatient rehabilitation. A prospective study.
Faller H; Hass HG; Engehausen D; Reuss-Borst M; Wöckel A
Acta Oncol; 2019 Apr; 58(4):417-424. PubMed ID: 30632891
[TBL] [Abstract][Full Text] [Related]
5. Palliative care experiences of adult cancer patients from ethnocultural groups: a qualitative systematic review protocol.
Busolo D; Woodgate R
JBI Database System Rev Implement Rep; 2015 Jan; 13(1):99-111. PubMed ID: 26447011
[TBL] [Abstract][Full Text] [Related]
6. A mixed-methods study of cyclin-dependent kinase 4 and 6 inhibitor symptom burden and quality of life among metastatic breast cancer patients and providers.
Oswald LB; Arredondo B; Kadono M; Martinez-Tyson D; Meade CD; Penedo F; Antoni MH; Soliman H; Costa RLB; Jim HSL
Cancer Med; 2021 Jul; 10(14):4823-4831. PubMed ID: 34165265
[TBL] [Abstract][Full Text] [Related]
7. Prospective exploratory analysis of the association between tumor response, quality of life, and expenditures among patients receiving paclitaxel monotherapy for refractory metastatic breast cancer.
Modi S; Panageas KS; Duck ET; Bach A; Weinstock N; Dougherty J; Cramer L; Hudis C; Norton L; Seidman A
J Clin Oncol; 2002 Sep; 20(17):3665-73. PubMed ID: 12202668
[TBL] [Abstract][Full Text] [Related]
8. Metastatic Breast Cancer Collateral Damage Project (MBCCD): Scale development and preliminary results of the Survey of Health, Impact, Needs, and Experiences (SHINE).
Williamson TJ; Love SM; Clague DeHart JN; Jorge-Miller A; Eshraghi L; Cooper Ortner H; Stanton AL
Breast Cancer Res Treat; 2018 Aug; 171(1):75-84. PubMed ID: 29767345
[TBL] [Abstract][Full Text] [Related]
9. Depression symptoms and health-related quality of life among patients with metastatic breast cancer in programme of palliative cancer care.
Slovacek L; Slovackova B; Slanska I; Petera J; Priester P; Filip S; Kopecky J
Neoplasma; 2009; 56(6):467-72. PubMed ID: 19873686
[TBL] [Abstract][Full Text] [Related]
10. Clinical Impact of Chemotherapy-Related Adverse Events in Patients with Metastatic Breast Cancer in an Integrated Health Care System.
Rashid N; Koh HA; Baca HC; Li Z; Malecha S; Abidoye O; Masaquel A
J Manag Care Spec Pharm; 2015 Oct; 21(10):863-71. PubMed ID: 26402387
[TBL] [Abstract][Full Text] [Related]
11. Use of the metastatic breast cancer progression (MBC-P) questionnaire to assess the value of progression-free survival for women with metastatic breast cancer.
Hurvitz SA; Lalla D; Crosby RD; Mathias SD
Breast Cancer Res Treat; 2013 Dec; 142(3):603-9. PubMed ID: 24218050
[TBL] [Abstract][Full Text] [Related]
12. Quality of life in metastatic breast cancer patients under chemotherapy or supportive care: a single-institution comparative study.
Karamouzis MV; Ioannidis G; Rigatos G
Eur J Cancer Care (Engl); 2007 Sep; 16(5):433-8. PubMed ID: 17760930
[TBL] [Abstract][Full Text] [Related]
13. Eribulin Mesylate as Third or Subsequent Line Chemotherapy for Elderly Patients with Locally Recurrent or Metastatic Breast Cancer: A Multicentric Observational Study of GIOGer (Italian Group of Geriatric Oncology)-ERIBE.
Leo S; Arnoldi E; Repetto L; Coccorullo Z; Cinieri S; Fedele P; Cazzaniga M; Lorusso V; Latorre A; Campanella G; Ciccarese M; Accettura C; Pisconti S; Rinaldi A; Brunetti C; Raffaele M; Coltelli L; Spazzapan S; Fratino L; Petrucelli L; Biganzoli L
Oncologist; 2019 Jun; 24(6):e232-e240. PubMed ID: 30413667
[TBL] [Abstract][Full Text] [Related]
14. Patient-reported Quality of Life and Treatment Satisfaction in Patients With HR
Wood R; Mitra D; de Courcy J; Iyer S
Clin Ther; 2017 Aug; 39(8):1719-1728. PubMed ID: 28751098
[TBL] [Abstract][Full Text] [Related]
15. The impact of hormonal treatments on quality of life of patients with metastatic breast cancer.
Costantino J
Clin Ther; 2002; 24 Suppl C():C26-42. PubMed ID: 12117073
[TBL] [Abstract][Full Text] [Related]
16. Outcome and feasibility of palliative chemotherapy in very elderly patients with metastatic breast cancer.
Overgaauw AJC; Speijers-van der Plas LM; Hendriks MP; Smorenburg CH
Breast J; 2020 Mar; 26(3):433-439. PubMed ID: 31538705
[TBL] [Abstract][Full Text] [Related]
17. Most prevalent unmet supportive care needs and quality of life of breast cancer patients in a tertiary hospital in Malaysia.
Edib Z; Kumarasamy V; Binti Abdullah N; Rizal AM; Al-Dubai SA
Health Qual Life Outcomes; 2016 Feb; 14():26. PubMed ID: 26898558
[TBL] [Abstract][Full Text] [Related]
18. ESAS and FACT-B in eribulin-treated metastatic breast cancer patients: a multicenter, prospective and observational study.
Moscetti L; Mentuccia L; Vici P; Quadrini S; Sperduti I; Pizzuti L; Fabbri MA; Vaccaro A; Maugeri-Saccà M; Barba M; Sergi D; Zampa G; Gamucci T
Future Oncol; 2017 Jul; 13(17):1517-1525. PubMed ID: 28429617
[TBL] [Abstract][Full Text] [Related]
19. Determinants of Last-line Treatment in Metastatic Breast Cancer.
Cinausero M; Gerratana L; De Carlo E; Iacono D; Bonotto M; Fanotto V; Buoro V; Basile D; Vitale MG; Rihawi K; Fasola G; Puglisi F
Clin Breast Cancer; 2018 Jun; 18(3):205-213. PubMed ID: 28781022
[TBL] [Abstract][Full Text] [Related]
20. Age and Gender Moderate the Impact of Early Palliative Care in Metastatic Non-Small Cell Lung Cancer.
Nipp RD; Greer JA; El-Jawahri A; Traeger L; Gallagher ER; Park ER; Jackson VA; Pirl WF; Temel JS
Oncologist; 2016 Jan; 21(1):119-26. PubMed ID: 26621041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
